Gene-targeting approach for herpes treatment
A new therapy being developed at the University of Florida could, in time, produce another weapon for the fight against herpes.
View ArticleStudy suggests that connective tissue growth factor plays a vital role in...
Accumulating evidence suggests that connective tissue growth factor (CCN2) plays a central role in fibrotic conditions in many organ systems. Fibrosis is a scarring condition that is characterized by...
View ArticleKylin Therapeutics receives notice of allowance for its first U.S. patent...
Officials of Kylin Therapeutics Inc., a leading RNAi company, announced that they have received a notice of allowance from the U.S. Patent and Trademark Office for its first U.S. patent application.
View ArticleHPA-specific shRNA holds potential as a novel therapeutic strategy for...
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression...
View ArticleScientists create tiny RNA molecule to synthesize proteins
An extremely small RNA molecule created by a University of Colorado at Boulder team can catalyze a key reaction needed to synthesize proteins, the building blocks of life. The findings could be a...
View ArticleOfficials of Kylin Therapeutics receive an issued patent from USPTO
Officials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office.
View ArticleResearchers develop CAD-type tools to engineer RNA control systems
The computer assisted design (CAD) tools that made it possible to fabricate integrated circuits with millions of transistors may soon be coming to the biological sciences. Researchers at the U.S....
View ArticleUltrastable RNA nanoparticles may help treat cancer and viral infections
A new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to...
View ArticlePaper details new target for anti-cancer drug development
In a new paper released today in Nature, BioFrontiers Institute scientists at the University of Colorado Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development...
View ArticleScioderm completes Series A financing commitment totaling $16 million
Scioderm, a company developing novel dermatology therapeutics, today announced the completion of a Series A financing commitment totaling $16 million. Morgenthaler Ventures led the Series A financing,...
View ArticleHomeostasis may have allowed first living cells to maintain internal environment
A Massachusetts General Hospital research team investigating how the earliest stages of life might have developed has discovered a way the first living cells could have met a key challenge --...
View ArticleTSRI scientists tackle decades-old challenge by re-creating primordial RNA world
Scientists at The Scripps Research Institute (TSRI) have taken a big step toward the laboratory re-creation of the “RNA world,” which is generally believed to have preceded modern life forms based on...
View ArticleUsing spherical nucleic acids to track and treat disease
Spherical nucleic acids are structures that are made by taking a nanoparticle template and using chemistry to arrange short strands of DNA or RNA on the surface of those particles. The spherical core...
View ArticleHPA-specific shRNA holds potential as a novel therapeutic strategy for...
Previous studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expression...
View ArticleScientists create tiny RNA molecule to synthesize proteins
An extremely small RNA molecule created by a University of Colorado at Boulder team can catalyze a key reaction needed to synthesize proteins, the building blocks of life. The findings could be a...
View ArticleOfficials of Kylin Therapeutics receive an issued patent from USPTO
Officials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office.
View ArticleResearchers develop CAD-type tools to engineer RNA control systems
The computer assisted design (CAD) tools that made it possible to fabricate integrated circuits with millions of transistors may soon be coming to the biological sciences. Researchers at the U.S....
View ArticleUltrastable RNA nanoparticles may help treat cancer and viral infections
A new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to...
View ArticlePaper details new target for anti-cancer drug development
In a new paper released today in Nature, BioFrontiers Institute scientists at the University of Colorado Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development...
View ArticleScioderm completes Series A financing commitment totaling $16 million
Scioderm, a company developing novel dermatology therapeutics, today announced the completion of a Series A financing commitment totaling $16 million. Morgenthaler Ventures led the Series A financing,...
View Article
More Pages to Explore .....